7-((1R,4R)-5-((6-fluoro-2,3,4,9-tetrahydro-1H-carbazol-3-yl)methyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)benzo[d]oxazol-2(3H)-one
7-((1R,4R)-5-((6-fluoro-2,3,4,9-tetrahydro-1H-carbazol-3-yl)methyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)benzo[d]oxazol-2(3H)-one
| SMILES |
C1CC2=C(CC1CN3CC4CC3CN4C5=CC=CC6=C5OC(=O)N6)C7=C(N2)C=CC(=C7)F |
| InChIKey |
JDKQOFWWKCLDDD-UHFFFAOYSA-N |
Chemical Properties
| Hydrogen bond acceptors |
4 |
| Hydrogen bond donors |
2 |
| Rotatable bonds |
3 |
| Molecular weight (Da) |
432.2 |
Bioactivities
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
7-((1R,4R)-5-((6-fluoro-2,3,4,9-tetrahydro-1H-carbazol-3-yl)methyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)benzo[d]oxazol-2(3H)-one
Drug properties
| Molecular type |
Small molecule |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Clinical Trials
Phase I
0
Phase II
0
Phase III
0
Approved
No
Sankey plot
Compound is not listed as a drug.